Gerresheimer, a manufacturer of primary packaging products for medication and drug delivery devices, agreed to acquire Bormioli Pharma Group, a manufacturer of pharmaceutical products, from Triton, a private equity firm, for €800m. "With this transaction, we are putting an exclamation mark on our growth ambitions. Bormioli Pharma is an ideal strategic fit for us and accelerates our transformation into an integrated systems and solutions provider. In particular, we are expanding our portfolio to include further high-value solutions. Both companies complement each other both in terms of product portfolio and regional coverage with production sites in Europe," Dietmar Siemssen, Gerresheimer CEO.